Due to impacts of COVID-19 and increased call volume, you may experience extended wait times when contacting our call center or messaging your provider via MyChart.
We appreciate your patience during this time and will return calls and messages as soon as possible. 
COVID-19 updates — testing, visitor guidelines and more | COVID-19 vaccine 

Skip to Content (Press Enter)
Back to results

Frances Austin, MD

Assistant professor
36 Ratings

Hematology and oncology, Solid tumor clinic


Fredericksburg Multispecialty Center
10528 Spotsylvania Avenue
Fredericksburg, VA 22408
View Location
Children's Pavilion
1000 East Broad Street
Richmond, VA 23219
View Location

Areas of interest

Sarcoma (Osteosarcoma
Ewing's Sarcoma
Renal Tumors ( Wilm's
and others)
Cancer predisposition syndromes


Dr. Austin is a member of the American Society of Pediatric Hematology-Oncology, American Society of Hematology, Children’s Oncology Group, American Society of Clinical Oncology and International Society of Paediatric Oncology. 


Medical School Drexel University School of Medicine, Philadelphia, PA
Residency St. Christopher's Hospital for Children, Philadelphia, PA
Fellowship Children's Hospital of Richmond at VCU

Research interests

Molecular biology of solid tumors


  • C Yang, F Austin, H Richard, M Idowa, V Williamson, F Sabato, A Ferrerira-Gonzalex, SA Turner. Lynch Syndromrome Associated ultra hypermutated pediatric glioblastoma mimicking a constitutional mismatch repair deficiency syndrome. Cold Spring Harb Mol Case Study. 2019 Oct 23:5(5). pii: a003863. doi: 10.1101/mcs.a003863.
  • F Austin, U Oyarbide, G Massey, M Grimes, S Corey. Synonymous mutation in TP53 results in cryptic splice site affecting its DNA binding site in an adolescent with two primary sarcomas. Pediatric Blood & Cancer. Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26584. Epub 2017 May 5.
  • PL Wagner, F Austin, M Zenati, A Mavanur, L Ramalingam, H Jones, M P Holtzman, S Ahrendt, AH Zureikat, JF Pingpank, HJ Zeh, DL Bartlett, H Choudry. Oncologic Risk Stratification Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendiceal Carcinomatosis. Ann Surg Oncol. 2016 May;23(5):1587-93. doi: 10.1245/s10434-015-5037-7.
  • D Magge, MS Zenati, F Austin, A Mavanur, M Sathaiah, L Ramalingam, H Jones, AH Zureikat, M Holtzman, S Ahrendt, J Pingpank, HJ Zeh, DL Bartlett, HA Choudry. Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis. Ann Surg Oncol. 2014 Apr;21(4):1159-65. doi: 10.1245/s10434-013-3358-y.
  • P Thirunavukarasu, M Sathaiah, MC Gorry , ME O'Malley, R Ravindranathan, F Austin, SH Thorne, ZS Guo, DL Bartlett. A rationally designed A34R mutant oncolytic poxvirus: improved efficacy in peritoneal carcinomatosis. Mol Ther. 2013 May;21(5):1024-33. doi: 10.1038/mt.2013.27.
  • PL Wagner, F Austin, U Maduekwe, A Mavanur, L Ramalingam, HL Jones, MP Holtzman, SA Ahrendt, AH Zureikat, JF Pingpank, HJ Zeh, DL Bartlett, HA Choudry. Extensive cytoreductive surgery for appendiceal carcinomatosis: morbidity, mortality, and survival. Ann Surg Oncol. 2013 Apr;20(4):1056-62. doi: 10.1245/s10434-012-2791-7.
  • PL Wagner, F Austin, M Sathaiah, D Magge, U Maduekwe, L Ramalingam, HL Jones, MP Holtzman, SA Ahrendt, AH Zureikat, JF Pingpank, HJ Zeh 3rd, DL Bartlett, HA Choudry. Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin. Ann Surg Oncol. 2013 Feb;20(2):506-14. doi: 10.1245/s10434-012-2627-5
  • F Austin, A Mavanur, M Sathaiah, J Steel, D Lanzner, L Ramalingam, M Holtzman, S Ahrent, J Pingpank, HJ Zeh, DL Bartlett, HA Choudry. Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms. Ann Surg Oncol. 2012 May; 19(5):1386-93.
  • M Sathaiah, P Thirunavukkarasu, ME O'Malley, MA Kavanagh, R Ravindranathan, F Austin, ZS Guo, DL Bartlett. Oncolytic poxvirus armed with Fas ligand leads to induction of cellular Fas receptor and selective viral replication in FasR-negative cancer. Cancer Gene Ther. 2012 March; 19(3):192-201.
  • ZS Guo, V Parimi, ME O'Malley, P Thirunavukarasu, M Sathaiah, F Austin, DL Bartlett. The combination of immunosuppression and carrier cells significantly enhances the efficacy of oncolytic poxvirus in the pre-immunized host. Gene Ther. 2010 December; 17(12):1465-75.
  • MF Ziauddin, ZS Guo, ME O’Malley, F Austin, PJ Popovic, MA Kavanagh, J Li, M Sathaiah, P Thirunavukkarasu, B Fang, YJ Lee, and DL Bartlett. TRAIL gene-armed oncolytic poxvirus and oxaliplatin can work synergistically against colorectal Cancer. Gene Ther. 2010 April; 17(4):550–559.

Ratings & reviews

36 Ratings

Learn more about the Press Ganey survey

October 2019
I've been to a lot of doctors because of different issues & this doctor was the best I've ever seen.
October 2019
Love Dr. Austin!
August 2019
Dr. Austin is awesome. She took her time and we didn't feel rushed. She answered all questions and concerns in a manner that we understood.
  • Specialty: Pediatric Hematology and Oncology Pediatric Solid Tumor Clini
physician practice phone number(540) 891-3173       

Board Certifications

Clinical Interests

  • Sarcoma (Osteosarcoma
  • Ewing's Sarcoma
  • Rhabdmyosarcoma)
  • Renal Tumors ( Wilm's
  • and others)
  • Hepatoblastoma
  • Cancer predisposition syndromes

Provider Videos